Fertility and Sterility
Volume 91, Issue 4, Supplement , Pages 1362-1365 , April 2009

Association between polymorphisms in the protein L-isoaspartate (D-aspartate) O-methyltransferase gene and premature ovarian failure

  • Jung-A. Pyun, B.S.
  • ,
  • HyunJun Kang, B.S.
  • ,
  • Seung Ku Lee, M.S.
  • ,
  • Min-ho Kim, M.S.
  • ,
  • KyuBum Kwack, Ph.D.

      Affiliations

    • Corresponding Author InformationReprint requests: KyuBum Kwack, Ph.D., Medical Genomics Laboratory, CHA Research Institute, Bundang Campus, Pochon CHA University, 222 Yatap-dong, Bundang-gu, Seongnam, Gyeonggi-do 463-836, Republic of Korea (FAX: 82-31-725-8350).

Received 26 November 2007 ,Revised 28 March 2008 ,Accepted 28 March 2008.

References 

  1. Conway GS. Premature ovarian failure. Br Med Bull. 2000;56:643–649
  2. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67:604–606
  3. Santoro N. Mechanisms of premature ovarian failure. Ann Endocrinol (Paris). 2003;64:87–92
  4. Timmreck LS, Reindollar RH. Contemporary issues in primary amenorrhea. Obstet Gynecol Clin North Am. 2003;30:287–302
  5. Aittomaki K, Lucena JL, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell. 1995;82:959–968
  6. Dixit H, Deendayal M, Singh L. Mutational analysis of the mature peptide region of inhibin genes in Indian women with ovarian failure. Hum Reprod. 2004;19:1760–1764
  7. Marozzi A, Porta C, Vegetti W, Crosignani PG, Tibiletti MG, Dalpra L, et al. Mutation analysis of the inhibin alpha gene in a cohort of Italian women affected by ovarian failure. Hum Reprod. 2002;17:1741–1745
  8. Matthews CH, Borgato S, Beck-Peccoz P, Adams M, Tone Y, Gambino G, et al. Primary amenorrhoea and infertility due to a mutation in the beta-subunit of follicle-stimulating hormone. Nat Genet. 1993;5:83–86
  9. Shelling AN, Burton KA, Chand AL, van Ee CC, France JT, Farquhar CM, et al. Inhibin: a candidate gene for premature ovarian failure. Hum Reprod. 2000;15:2644–2649
  10. Conway GS, Conway E, Walker C, Hoppner W, Gromoll J, Simoni M. Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome. Clin Endocrinol (Oxf). 1999;51:97–99
  11. Jeong HJ, Cho SW, Kim HA, Lee SH, Cho JH, Choi DH, et al. G769A variation of inhibin alpha-gene in korean women with premature ovarian failure. Yonsei Med J. 2004;45:479–482
  12. Jiang M, Aittomaki K, Nilsson C, Pakarinen P, Iitia A, Torresani T, et al. The frequency of an inactivating point mutation (566C→T) of the human follicle-stimulating hormone receptor gene in four populations using allele-specific hybridization and time-resolved fluorometry. J Clin Endocrinol Metab. 1998;83:4338–4343
  13. Layman LC, Amde S, Cohen DP, Jin M, Xie J. The Finnish follicle-stimulating hormone receptor gene mutation is rare in North American women with 46,XX ovarian failure. Fertil Steril. 1998;69:300–302
  14. Layman LC, Shelley ME, Huey LO, Wall SW, Tho SP, McDonough PG. Follicle-stimulating hormone beta gene structure in premature ovarian failure. Fertil Steril. 1993;60:852–857
  15. Sundblad V, Chiauzzi VA, Andreone L, Campo S, Charreau EH, Dain L. Controversial role of inhibin alpha-subunit gene in the aetiology of premature ovarian failure. Hum Reprod. 2006;21:1154–1160
  16. Burchard EG, Ziv E, Coyle N, Gomez SL, Tang H, Karter AJ, et al. The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med. 2003;348:1170–1175
  17. Phimister EG. Medicine and the racial divide. N Engl J Med. 2003;348:1081–1082
  18. Syvanen AC. Toward genome-wide SNP genotyping. Nat Genet. 2005;37(Suppl):S5–S10
  19. Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet. 2005;6:95–108
  20. Collins FS, Guyer MS, Charkravarti A. Variations on a theme: cataloging human DNA sequence variation. Science. 1997;278:1580–1581
  21. Kruglyak L. Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet. 1999;22:139–144
  22. Risch NJ. Searching for genetic determinants in the new millennium. Nature. 2000;405:847–856
  23. Clarke S. Aging as war between chemical and biochemical processes: protein methylation and the recognition of age-damaged proteins for repair. Ageing Res Rev. 2003;2:263–285
  24. Lindner H, Helliger W. Age-dependent deamidation of asparagine residues in proteins. Exp Gerontol. 2001;36:1551–1563
  25. Brennan TV, Anderson JW, Jia Z, Waygood EB, Clarke S. Repair of spontaneously deamidated HPr phosphocarrier protein catalyzed by the L-isoaspartate-(D-aspartate) O-methyltransferase. J Biol Chem. 1994;269:24586–24595
  26. Galletti P, Ingrosso D, Manna C, Clemente G, Zappia V. Protein damage and methylation-mediated repair in the erythrocyte. Biochem J. 1995;306:313–325
  27. Ingrosso D, D'Angelo S, di Carlo E, Perna AF, Zappia V, Galletti P. Increased methyl esterification of altered aspartyl residues in erythrocyte membrane proteins in response to oxidative stress. Eur J Biochem. 2000;267:4397–4405
  28. Johnson BA, Langmack EL, Aswad DW. Partial repair of deamidation-damaged calmodulin by protein carboxyl methyltransferase. J Biol Chem. 1987;262:12283–12287
  29. Johnson BA, Murray ED, Clarke S, Glass DB, Aswad DW. Protein carboxyl methyltransferase facilitates conversion of atypical L-isoaspartyl peptides to normal L-aspartyl peptides. J Biol Chem. 1987;262:5622–5629
  30. Lanthier J, Desrosiers RR. Protein L-isoaspartyl methyltransferase repairs abnormal aspartyl residues accumulated in vivo in type-I collagen and restores cell migration. Exp Cell Res. 2004;293:96–105
  31. McFadden PN, Clarke S. Conversion of isoaspartyl peptides to normal peptides: implications for the cellular repair of damaged proteins. Proc Natl Acad Sci USA. 1987;84:2595–2599
  32. Reissner KJ, Aswad DW. Deamidation and isoaspartate formation in proteins: unwanted alterations or surreptitious signals?. Cell Mol Life Sci. 2003;60:1281–1295
  33. Robinson NE, Robinson ZW, Robinson BR, Robinson AL, Robinson JA, Robinson ML, et al. Structure-dependent nonenzymatic deamidation of glutaminyl and asparaginyl pentapeptides. J Pept Res. 2004;63:426–436
  34. Shimizu T, Matsuoka Y, Shirasawa T. Biological significance of isoaspartate and its repair system. Biol Pharm Bull. 2005;28:1590–1596
  35. Diliberto EJ, Axelrod J. Regional and subcellular distribution of protein carboxymethylase in brain and other tissues. J Neurochem. 1976;26:1159–1165
  36. Kim E, Lowenson JD, MacLaren DC, Clarke S, Young SG. Deficiency of a protein-repair enzyme results in the accumulation of altered proteins, retardation of growth, and fatal seizures in mice. Proc Natl Acad Sci USA. 1997;94:6132–6137
  37. MacLaren DC, Kagan RM, Clarke S. Alternative splicing of the human isoaspartyl protein carboxyl methyltransferase RNA leads to the generation of a C-terminal -RDEL sequence in isozyme II. Biochem Biophys Res Commun. 1992;185:277–283
  38. Yamamoto A, Takagi H, Kitamura D, Tatsuoka H, Nakano H, Kawano H, et al. Deficiency in protein L-isoaspartyl methyltransferase results in a fatal progressive epilepsy. J Neurosci. 1998;18:2063–2074
  39. Zhu H, Yang W, Lu W, Zhang J, Shaw GM, Lammer EJ, et al. A known functional polymorphism (Ile120Val) of the human PCMT1 gene and risk of spina bifida. Mol Genet Metab. 2006;87:66–70
  40. Iwatsubo T, Saido TC, Mann DM, Lee VM, Trojanowski JQ. Full-length amyloid-beta (1-42(43)) and amino-terminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques. Am J Pathol. 1996;149:1823–1830
  41. Roher AE, Lowenson JD, Clarke S, Wolkow C, Wang R, Cotter RJ, et al. Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem. 1993;268:3072–3083
  42. Shimizu T, Fukuda H, Murayama S, Izumiyama N, Shirasawa T. Isoaspartate formation at position 23 of amyloid beta peptide enhanced fibril formation and deposited onto senile plaques and vascular amyloids in Alzheimer's disease. J Neurosci Res. 2002;70:451–461
  43. Shimizu T, Watanabe A, Ogawara M, Mori H, Shirasawa T. Isoaspartate formation and neurodegeneration in Alzheimer's disease. Arch Biochem Biophys. 2000;381:225–234
  44. DeVry CG, Clarke S. Polymorphic forms of the protein L-isoaspartate (D-aspartate) O-methyltransferase involved in the repair of age-damaged proteins. J Hum Genet. 1999;44:275–288
  45. Capasso S, Di Donato A, Esposito L, Sica F, Sorrentino G, Vitagliano L, et al. Deamidation in proteins: the crystal structure of bovine pancreatic ribonuclease with an isoaspartyl residue at position 67. J Mol Biol. 1996;257:492–496
  46. Paranandi MV, Aswad DW. Spontaneous alterations in the covalent structure of synapsin I during in vitro aging. Biochem Biophys Res Commun. 1995;212:442–448
  47. Deverman BE, Cook BL, Manson SR, Niederhoff RA, Langer EM, Rosova I, et al. Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage. Cell. 2002;111:51–62
  48. Pepperkok R, Hotz-Wagenblatt A, Konig N, Girod A, Bossemeyer D, Kinzel V. Intracellular distribution of mammalian protein kinase A catalytic subunit altered by conserved Asn2 deamidation. J Cell Biol. 2000;148:715–726
  49. Axelrod J, Daly J. Pituitary gland: enzymic formation of methanol from S-adenosylmethionine. Science. 1965;150:892–893
  50. Ciaranello RD, Dankers HJ, Barchas JD. The enzymatic formation of methanol from S-adenosylmethionine by various tissues of the rat. Mol Pharmacol. 1972;8:311–317
  51. Diliberto EJ, Axelrod J. Characterization and substrate specificity of a protein carboxymethylase in the pituitary gland. Proc Natl Acad Sci USA. 1974;71:1701–1704
  52. NCBI UniGene EST Profile Viewer: expression profile suggested by analysis of EST counts. Hs.279257-PCMT1: Protein-L-isoaspartate (D-aspartate) O-methyltransferase. Available at: http://www.ncbi.nlm.nih.gov/UniGene/ESTProfileViewer.cgi?uglist=Hs.279257
  53. Jetly NM, Iyer KS, Hosur MV, Mahale SD. Attempt to map the receptor binding sites of human follicle-stimulating hormone using disulfide peptides of its beta-subunit indicates major involvement of the regions around disulfide bonds Cys28-Cys82 and Cys32-Cys84 in receptor binding of the hormone. J Pept Res. 2003;62:269–279
  54. Johnson BA, Shirokawa JM, Geddes JW, Choi BH, Kim RC, Aswad DW. Protein L-isoaspartyl methyltransferase in postmortem brains of aged humans. Neurobiol Aging. 1991;12:19–24

 Supported by grants from Ministry of Health and Welfare, Republic of Korea (01-PJ10-PG6-01GN13-0002 and 0405-BC02-0604-0004).

 J-A.P. has nothing to disclose. HJ.K. has nothing to disclose. S.K.L. has nothing to disclose. M.K. has nothing to disclose. KB.K. has nothing to disclose.

PII: S0015-0282(08)00753-X

doi: 10.1016/j.fertnstert.2008.03.078

Fertility and Sterility
Volume 91, Issue 4, Supplement , Pages 1362-1365 , April 2009